Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

Figure 2

The correlation between serum clusterin levels and mortality of patients with HBV-related acute-on-chronic liver failure and value of serum clusterin for predicting short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure. (a) Comparison of mortality in HBV-ACLF patients between four different concentration gradients of serum clusterin. (b) The AUCs of MELD score, CLIF-C ACLF score, and clusterin for predicting prognosis of HBV-ACLF. Abbreviations: HBV-ACLF: hepatitis B virus-related acute-on-chronic liver failure; MELD: model for end-stage liver disease; CLIF-C ACLF: chronic liver failure consortium on acute chronic liver failure.

(a)

(b)